Winthrop Advisory Group’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-2,182
Closed -$226K 159
2024
Q3
$226K Sell
2,182
-78
-3% -$7.95K 0.03% 132
2024
Q2
$219K Sell
2,260
-14
-0.6% -$1.29K 0.03% 129
2024
Q1
$205K Buy
+2,274
New +$193K 0.03% 135
2022
Q3
Sell
-2,535
Closed -$203K 120
2022
Q2
$203K Buy
+2,535
New +$198K 0.05% 114
2022
Q1
Sell
-2,435
Closed -$208K 140
2021
Q4
$208K Buy
+2,435
New +$190K 0.04% 134
2019
Q4
Sell
-3,226
Closed -$237K 102
2019
Q3
$237K Buy
3,226
+14
+0.4% +$1.02K 0.09% 82
2019
Q2
$230K Sell
3,212
-186
-5% -$13.2K 0.1% 80
2019
Q1
$233K Buy
+3,398
New +$219K 0.1% 83
2018
Q4
Sell
-3,127
Closed -$209K 90
2018
Q3
$209K Buy
3,127
+10
+0.3% +$666 0.12% 83
2018
Q2
$202K Sell
3,117
-389
-11% -$25.4K 0.13% 77
2018
Q1
$233K Sell
3,506
-111
-3% -$7.99K 0.16% 70
2017
Q4
$270K Buy
+3,617
New +$264K 0.19% 65

Other funds holding CL

Winthrop Advisory Group's CL Position: Q4 2024 in Review

Winthrop Advisory Group sold out of Colgate-Palmolive (CL) in Q4 2024, closing a stake of 2,182 shares — an estimated $226K sold.

Winthrop Advisory Group first reported a position in CL in Q4 2017 and held it in 12 quarters. The position peaked at $270K in Q4 2017. 1,932 funds tracked by Wall St. Rank hold CL as of Q4 2024.

  • Winthrop Advisory Group reported no remaining Colgate-Palmolive position as of Q4 2024 after selling out during the quarter.
  • Winthrop Advisory Group sold 2,182 Colgate-Palmolive shares in Q4 2024, an estimated $226K.
  • Winthrop Advisory Group first reported a position in Colgate-Palmolive in Q4 2017 and held it in 12 quarters.
  • Winthrop Advisory Group's Colgate-Palmolive position peaked at $270K in Q4 2017.
  • 1,932 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2024.

Based on Winthrop Advisory Group's 13F filing for Q4 2024, filed 13 Jan 2025.